Head to Head Review: Dynatronics (NASDAQ:DYNT) versus Motus GI (NASDAQ:MOTS)

Share on StockTwits

Motus GI (NASDAQ:MOTS) and Dynatronics (NASDAQ:DYNT) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership and profitability.

Profitability

This table compares Motus GI and Dynatronics’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Motus GI N/A -143.60% -107.10%
Dynatronics -1.84% -12.16% -2.84%

Analyst Recommendations

This is a summary of recent ratings and target prices for Motus GI and Dynatronics, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Motus GI 0 0 2 0 3.00
Dynatronics 0 0 3 0 3.00

Motus GI currently has a consensus target price of $7.67, indicating a potential upside of 320.09%. Dynatronics has a consensus target price of $3.50, indicating a potential upside of 379.45%. Given Dynatronics’ higher probable upside, analysts clearly believe Dynatronics is more favorable than Motus GI.

Risk and Volatility

Motus GI has a beta of 1.52, meaning that its stock price is 52% more volatile than the S&P 500. Comparatively, Dynatronics has a beta of 0.02, meaning that its stock price is 98% less volatile than the S&P 500.

Earnings & Valuation

This table compares Motus GI and Dynatronics’ revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Motus GI $40,000.00 1,313.82 -$22.26 million ($1.23) -1.48
Dynatronics $62.56 million 0.10 -$920,000.00 ($0.21) -3.48

Dynatronics has higher revenue and earnings than Motus GI. Dynatronics is trading at a lower price-to-earnings ratio than Motus GI, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

43.3% of Motus GI shares are owned by institutional investors. Comparatively, 11.7% of Dynatronics shares are owned by institutional investors. 18.1% of Motus GI shares are owned by company insiders. Comparatively, 22.7% of Dynatronics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Dynatronics beats Motus GI on 8 of the 13 factors compared between the two stocks.

Motus GI Company Profile

Motus GI Holdings, Inc. operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The company is based in Fort Lauderdale, Florida.

Dynatronics Company Profile

Dynatronics Corporation designs, manufactures, markets, and distributes orthopedic soft goods, medical supplies, and physical therapy and rehabilitation equipment in the United States and internationally. It offers ankle and wrist braces, hot packs, cold packs, lumbar rolls, cervical collars, slings, cervical pillows, bolsters, positioning wedges, back cushions, lotions and gels, paper products, athletic tape, splints, elastic wraps, exercise weights, exercise bands and tubing, electrodes, and rehabilitation and back products. The company also provides electrotherapy, ultrasound, phototherapy, and thermal therapy modalities; motorized and stationary treatment tables and mat platforms; custom athletic training equipment; and strength and cardio training equipment. In addition, it distributes a range of products, such as exercise equipment, treatment tables, treadmills, walkers, compression therapy devices, stair climbers, parallel bars, laser light therapy equipment, shortwave diathermy, and radial pulse equipment. The company sells its products to licensed practitioners, such as orthopedists, physical therapists, chiropractors, and athletic trainers, professional sports teams and universities, sports medicine specialists, post-acute care facilities, hospitals and clinics, retail distributors and equipment manufacturer partners through direct and independent sales representatives and independent dealers. It also exports its products to approximately 30 countries. The company was founded in 1979 and is headquartered in Cottonwood Heights, Utah.

Receive News & Ratings for Motus GI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motus GI and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

QuickLogic  Downgraded by Zacks Investment Research to Sell
QuickLogic Downgraded by Zacks Investment Research to Sell
Regeneron Pharmaceuticals  Upgraded to “Buy” by BidaskClub
Regeneron Pharmaceuticals Upgraded to “Buy” by BidaskClub
Proofpoint  Raised to “Buy” at BidaskClub
Proofpoint Raised to “Buy” at BidaskClub
Omeros  Upgraded at BidaskClub
Omeros Upgraded at BidaskClub
360 Finance  Rating Increased to Buy at ValuEngine
360 Finance Rating Increased to Buy at ValuEngine
Kiniksa Pharmaceuticals  Downgraded by Zacks Investment Research to “Sell”
Kiniksa Pharmaceuticals Downgraded by Zacks Investment Research to “Sell”


 
© 2006-2020 Zolmax.